Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies

NCT06187870 | Recruiting

• 1 other identifier: URBBAN
• Study Type: observational
• Target: 15,000
• Locations: 1 country
• Sites: 1

Brief Summary

The project aims to collect fresh biological material derived both from surgical resections performed in diseases, neoplastic and otherwise, of urological relevance at the level of the prostate, bladder, kidney, testicle and genitourinary organs, and from peripheral blood or other fluids biological samples such as urine, seminal fluid, buccal mucosa, feces or saliva, when available.

Conditions

Urologic Diseases; Urologic Cancer; Infertility

Outcome Measures

Primary Outcomes (1)

• Biological sample

  A biobank is a facility aimed at the collection, management, preservation and distribution of biomaterials and related data for research purposes

  Baseline

Interventions

Collection of biological data OTHER

Biological samples will be collected from the patient at the time of their access to the Hospital

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

People with urological or uro-oncological diseases and infertility

You may qualify if:

• Male and female patients with an age \> 18
• Ability to read and sign the informed consent
• patients affected by urological or uro-oncological diseases

You may not qualify if:

• People with an age \< 18
• Incapacity to read and sign the informed consent

Sponsors & Collaborators

• IRCCS San Raffaele: lead

Study Sites (1)

IRCCS Ospedale San Raffaele

Milan, Lombardy, 20132, Italy

RECRUITING

MeSH Terms

Conditions

Urologic Diseases; Urologic Neoplasms; Infertility

Condition Hierarchy (Ancestors)

Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases

Central Study Contacts

Anna Maria Ferrara

CONTACT

0226437795; ferrara.annamaria@hsr.it

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof

Study Record Dates

• First Submitted: December 14, 2023
• First Posted: January 3, 2024
• Study Start: October 7, 2010
• Primary Completion (Estimated): October 6, 2030
• Study Completion (Estimated): October 6, 2030
• Last Updated: January 10, 2024

Record last verified: 2023-12

Data Sharing

• IPD Sharing: Will not share

Locations

IT (1)